Next quarter’s earnings estimate for RO is CHF8.55 with a range of CHF8.16 to CHF8.99. The previous quarter’s EPS was CHF11.08. RO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RO has Performed in-line its overall industry.
Next quarter’s earnings estimate for RO is CHF8.55 with a range of CHF8.16 to CHF8.99. The previous quarter’s EPS was CHF11.08. RO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RO has Performed in-line its overall industry.
RO Sales Forecast
Next quarter’s sales forecast for RO is CHF15.55B with a range of CHF14.96B to CHF16.13B. The previous quarter’s sales results were CHF30.94B. RO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RO has Performed in-line its overall industry.
Next quarter’s sales forecast for RO is CHF15.55B with a range of CHF14.96B to CHF16.13B. The previous quarter’s sales results were CHF30.94B. RO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RO has Performed in-line its overall industry.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
No data currently available
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
No data currently available
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of -0.66% per trade.
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +12.24% per trade.
Copying Veda Pharmyne's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.38% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +14.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RO Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
5
8
11
8
6
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
8
11
8
6
In the current month, RO has received 6Buy Ratings, 0Hold Ratings, and 0Sell Ratings. RO average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
RO Stock Forecast FAQ
What is CH:RO’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:RO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:RO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Roche Holding Ltd a Buy, Sell or Hold?
Roche Holding Ltd has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Roche Holding Ltd’s share price target?
Currently, no data Available
What do analysts say about Roche Holding Ltd?
Roche Holding Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Roche Holding Ltd?
To buy shares of CH:RO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.